Common Antidepressant May Slow Parkinson’s Disease Progression
Summary: Researchers report that a long-established antidepressant may slow progression of Parkinson’s disease by blocking the aggregation of alpha-synuclein proteins. Longstanding Antidepressant Shows Early Potential to Slow Parkinson’s Progression Michigan State University researchers have produced early evidence that nortriptyline, an antidepressant used for more than five decades, could slow the progression of Parkinson’s disease. In … Read more